Clinical Trials Logo

Hand-foot Skin Reaction clinical trials

View clinical trials related to Hand-foot Skin Reaction.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03229512 Completed - Clinical trials for Hand Foot Skin Reaction

Topical Sildenafil as Pre-Treatment for Hand-Foot Skin Reaction

Start date: April 11, 2017
Phase: Early Phase 1
Study type: Interventional

Skin toxicities are a major complication to cancer therapies. They can be painful and limit the amount of drug that can be received by cancer patients, preventing the patients from receiving optimal doses of drug. One such cutaneous toxicity, hand-foot skin reaction (HFSR), is caused by next generation targeted agents that are in routine use for the treatment of kidney and liver cancer. HFSR is characterized by swelling, redness, and pain of the palms and soles, in addition to the development of painful or thickened callus-like plaques with fissures in areas of friction and pressure. The investigators have identified a topical skin-directed therapy, 1% topical sildenafil cream, that the investigators believe will be useful in preventing and ameliorating this painful, skin side effect associated with the targeted agents sorafenib and sunitinib. This project proposal aims to conduct an open-label pilot study to assess whether pre-medication with this cream can be an effective way of preventing or decreasing the severity of hand-foot skin reaction, improving their quality of life on therapy and enabling the patients to receive optimal amounts of their anti-cancer drug.